Skip to main content
OpenTrials
Completed

NCT Number: NCT00325520

A Neurocognitive Model of Anorexia Nervosa

The purpose of this study is to investigate thought processes and neural mechanisms that may contribute to the development of habitual behaviors. The investigators hypothesize that patients with AN will perform differently than people without eating disorders on a series of neuropsychological tasks and will show different neural activation patterns in functional neuroimaging scans.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–45 year

Sex eligibility

All sexes

Study type

Observational

About this study

Patients with Anorexia Nervosa (AN) have extreme difficulty changing their eating behavior, even when they express desire for change. These behaviors seem to override all other potential responses, and can appear perseverative, or habitual. The purpose of this study is to investigate thought processes and neural mechanisms that may contribute to the development of habitual behaviors. The investigators hypothesize that patients with AN will perform differently than people without eating disorders on a series of neuropsychological tasks and will show different neural activation patterns in functional neuroimaging scans.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion:

  • DSM-IV-TR™ diagnosis of anorexia nervosa (restricting or binge-purge subtype), current or prior;
  • Age 16-45;
  • Inpatient on GCRU
  • Medically stable.

Exclusion:

  • Any other current major Axis I disorder (including current bulimia nervosa), except major depression;
  • History of concussion, seizure disorder, or other neurological illness;
  • History of learning disability;
  • Acute Suicidality

Healthy comparison group:

Inclusion:

  • No current or past psychiatric illness;
  • Age 16-45
  • No history of binge eating or vomiting;
  • Normal weight (80%-120% ideal body weight)

Exclusion:

  • Significant medical or neurologic illness(concussion, seizure disorder, learning disability, other neurological illness)
  • Current psychotropic medication or medications known to impact cognition

Additional Exclusion Criteria for fMRI:

  • Significant Claustrophobia
  • Pregnancy
  • Indwelling metallic object, non-removable metal jewelry, medicinal patch or recent metallic ink tattoo
  • For patients, current psychotropic medications (antidepressants for 2 week (prozac and antipsychotics for 4 weeks)
  • For patients, any other current Axis I diagnosis

Treatment and study plan

Primary outcomes

  1. Neuropsychological functioning

    Time frame: pre- and post-treatment

Sponsors and collaborators

Lead sponsor

New York State Psychiatric Institute

Other

Collaborators

  • Klarman Family Foundation
  • National Institute of Mental Health (NIMH)

Registry information

Important dates

Study start
2006
Primary completion
2014
Study completion
2014
First posted
May 15, 2006
Registry last updated
Aug 15, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.